1667TiP A phase II, single arm study of avelumab in combination with axitinib in patients with unresectable/metastatic gastrointestinal stromal tumor after failure of standard therapy - AXAGIST

Autor: Kozak, K., Pantaleo, M.A., Fumagalli, E., Nannini, M., Bylina, E., Poleszczuk, J., Klimczak, A., Casali, P.G., Rutkowski, P.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S990-S990
Databáze: ScienceDirect